Böbrek taşı (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Böbrek taşı" in Turkish language version.

refsWebsite

Global rank Turkish rank

32nih.gov

4^th place

11^th place

25doi.org

2^nd place

4^th place

13web.archive.org

1^st place

11worldcat.org

5^th place

8^th place

7ccjm.org

low place

3abdulkerimustun.com

low place

2books.google.com

3^rd place

5^th place

abdulkerimustun.com

"Arşivlenmiş kopya". 8 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.
"Arşivlenmiş kopya". 8 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.
"Arşivlenmiş kopya". 8 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.

books.google.com

Schulsinger, David A. (2014). Kidney Stone Disease: Say NO to Stones! (İngilizce). Springer. s. 27. ISBN 9783319121055. 8 Eylül 2017 tarihinde kaynağından arşivlendi.
Knoll T, Pearle MS (2012). Clinical Management of Urolithiasis (İngilizce). Springer Science & Business Media. s. 21. ISBN 9783642287329. 8 Eylül 2017 tarihinde kaynağından arşivlendi.

ccjm.org

Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.

doi.org

Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD (November 2014). "Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians". Annals of Internal Medicine. 161 (9): 659-67. doi:10.7326/M13-2908 . PMID 25364887.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, ve diğerleri. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545-1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577 $2. PMID 27733282.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, ve diğerleri. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459-1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903 $2. PMID 27733281.
Miller NL, Lingeman JE (March 2007). "Management of kidney stones". BMJ. 334 (7591): 468-72. doi:10.1136/bmj.39113.480185.80. PMC 1808123 $2. PMID 17332586.
Morgan, Monica S C; Pearle, Margaret S (2016). "Medical management of renal stones". BMJ. 352: i52. doi:10.1136/bmj.i52. ISSN 1756-1833. PMID 26977089.
Morgan, Monica S C; Pearle, Margaret S (2016). "Medical management of renal stones". BMJ. 352: i52. doi:10.1136/bmj.i52. ISSN 1756-1833. PMID 26977089.
Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ (February 1996). "Prospective study of beverage use and the risk of kidney stones". American Journal of Epidemiology. 143 (3): 240-7. doi:10.1093/oxfordjournals.aje.a008734 . PMID 8561157.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN (October 2016). "Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones". Clinical Journal of the American Society of Nephrology. 11 (10): 1834-1844. doi:10.2215/CJN.01520216. PMC 5053786 $2. PMID 27445166.
Riley JM, Kim H, Averch TD, Kim HJ (December 2013). "Effect of magnesium on calcium and oxalate ion binding". Journal of Endourology. 27 (12): 1487-92. doi:10.1089/end.2013.0173. PMC 3883082 $2. PMID 24127630.
Ferraro PM, Curhan GC, Gambaro G, Taylor EN (March 2016). "Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones". American Journal of Kidney Diseases. 67 (3): 400-7. doi:10.1053/j.ajkd.2015.09.005. PMC 4769668 $2. PMID 26463139.
Ferraro PM, Curhan GC, Gambaro G, Taylor EN (March 2016). "Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones". American Journal of Kidney Diseases. 67 (3): 400-7. doi:10.1053/j.ajkd.2015.09.005. PMC 4769668 $2. PMID 26463139.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Afshar K, Jafari S, Marks AJ, Eftekhari A, MacNeily AE (June 2015). "Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic". The Cochrane Database of Systematic Reviews. 6 (6): CD006027. doi:10.1002/14651858.CD006027.pub2. PMID 26120804.
Wang RC, Smith-Bindman R, Whitaker E, Neilson J, Allen IE, Stoller ML, Fahimi J (March 2017). "Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis". Annals of Emergency Medicine. 69 (3): 353-361.e3. doi:10.1016/j.annemergmed.2016.06.044 . PMID 27616037.

nih.gov

ncbi.nlm.nih.gov

Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD (November 2014). "Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians". Annals of Internal Medicine. 161 (9): 659-67. doi:10.7326/M13-2908 . PMID 25364887.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, ve diğerleri. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545-1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577 $2. PMID 27733282.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, ve diğerleri. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459-1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903 $2. PMID 27733281.
Miller NL, Lingeman JE (March 2007). "Management of kidney stones". BMJ. 334 (7591): 468-72. doi:10.1136/bmj.39113.480185.80. PMC 1808123 $2. PMID 17332586.
Morgan, Monica S C; Pearle, Margaret S (2016). "Medical management of renal stones". BMJ. 352: i52. doi:10.1136/bmj.i52. ISSN 1756-1833. PMID 26977089.
Morgan, Monica S C; Pearle, Margaret S (2016). "Medical management of renal stones". BMJ. 352: i52. doi:10.1136/bmj.i52. ISSN 1756-1833. PMID 26977089.
Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ (February 1996). "Prospective study of beverage use and the risk of kidney stones". American Journal of Epidemiology. 143 (3): 240-7. doi:10.1093/oxfordjournals.aje.a008734 . PMID 8561157.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN (October 2016). "Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones". Clinical Journal of the American Society of Nephrology. 11 (10): 1834-1844. doi:10.2215/CJN.01520216. PMC 5053786 $2. PMID 27445166.
Riley JM, Kim H, Averch TD, Kim HJ (December 2013). "Effect of magnesium on calcium and oxalate ion binding". Journal of Endourology. 27 (12): 1487-92. doi:10.1089/end.2013.0173. PMC 3883082 $2. PMID 24127630.
Negri AL, Spivacow FR, Del Valle EE (2013). "[Diet in the treatment of renal lithiasis. Pathophysiological basis]". Medicina. 73 (3): 267-71. PMID 23732207.
Negri AL, Spivacow FR, Del Valle EE (2013). "[Diet in the treatment of renal lithiasis. Pathophysiological basis]". Medicina. 73 (3): 267-71. PMID 23732207.
Traxer O, Pearle MS, Gattegno B, Thibault P (December 2003). "[Vitamin C and stone risk. Review of the literature]". Progres en Urologie. 13 (6): 1290-4. PMID 15000301.
Ferraro PM, Curhan GC, Gambaro G, Taylor EN (March 2016). "Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones". American Journal of Kidney Diseases. 67 (3): 400-7. doi:10.1053/j.ajkd.2015.09.005. PMC 4769668 $2. PMID 26463139.
Ferraro PM, Curhan GC, Gambaro G, Taylor EN (March 2016). "Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones". American Journal of Kidney Diseases. 67 (3): 400-7. doi:10.1053/j.ajkd.2015.09.005. PMC 4769668 $2. PMID 26463139.
Brawer MK, Makarov DV, Partin AW, Roehrborn CG, Nickel JC, Lu SH, Yoshimura N, Chancellor MB, Assimos DG (2008). "Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL". Reviews in Urology. 10 (2): 136-56. PMC 2483319 $2. PMID 18660856.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL (Dec 2014). "What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?". International Brazilian Journal of Urology. 40 (6): 772-80. doi:10.1590/S1677-5538.IBJU.2014.06.08 . PMID 25615245.
del Valle EE, Spivacow FR, Negri AL (2013). "[Citrate and renal stones]". Medicina. 73 (4): 363-8. PMID 23924538.
Caudarella R, Vescini F (September 2009). "Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment". Archivio Italiano di Urologia, Andrologia. 81 (3): 182-7. PMID 19911682.
Afshar K, Jafari S, Marks AJ, Eftekhari A, MacNeily AE (June 2015). "Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic". The Cochrane Database of Systematic Reviews. 6 (6): CD006027. doi:10.1002/14651858.CD006027.pub2. PMID 26120804.
Wang RC, Smith-Bindman R, Whitaker E, Neilson J, Allen IE, Stoller ML, Fahimi J (March 2017). "Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis". Annals of Emergency Medicine. 69 (3): 353-361.e3. doi:10.1016/j.annemergmed.2016.06.044 . PMID 27616037.

niddk.nih.gov

"Kidney Stones in Adults". February 2013. 11 Mayıs 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Mayıs 2015.

web.archive.org

Schulsinger, David A. (2014). Kidney Stone Disease: Say NO to Stones! (İngilizce). Springer. s. 27. ISBN 9783319121055. 8 Eylül 2017 tarihinde kaynağından arşivlendi.
"Kidney Stones in Adults". February 2013. 11 Mayıs 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Mayıs 2015.
Knoll T, Pearle MS (2012). Clinical Management of Urolithiasis (İngilizce). Springer Science & Business Media. s. 21. ISBN 9783642287329. 8 Eylül 2017 tarihinde kaynağından arşivlendi.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). "Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease". Cleveland Clinic Quarterly. 41 (3): 109-17. doi:10.3949/ccjm.41.3.109. PMID 4416806. 20 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Temmuz 2021.
"Arşivlenmiş kopya". 8 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.
"Arşivlenmiş kopya". 8 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.
"Arşivlenmiş kopya". 8 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2016.

worldcat.org

Morgan, Monica S C; Pearle, Margaret S (2016). "Medical management of renal stones". BMJ. 352: i52. doi:10.1136/bmj.i52. ISSN 1756-1833. PMID 26977089.
Morgan, Monica S C; Pearle, Margaret S (2016). "Medical management of renal stones". BMJ. 352: i52. doi:10.1136/bmj.i52. ISSN 1756-1833. PMID 26977089.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.
Lewis SM (2017). Medical-surgical nursing : assessment and management of clinical problems. ISBN 978-0-323-32852-4. OCLC 944472408.